
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
20,250 | 20,290 | 03.04. | |
20,285 | 20,320 | 03.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01:59 | Eli Lilly boss: 'Tariffs are pivotal moment and hard to come back from' | ||
Do | Eli Lilly to leverage Sangamo capsid technology for CNS disease therapies | ||
Do | Sangamo Therapeutics stock soars on Lilly licensing deal | ||
Do | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System | Agreement grants Lilly rights to employ Sangamo's novel proprietary capsid, STAC-BBB, for up to five potential disease targets Sangamo to receive an $18 million upfront license fee and... ► Artikel lesen | |
Do | DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
02:38 | Report: TSMC tentatively agrees to establish chipmaking joint venture with Intel | ||
00:26 | Analyst Says Intel (INTC) Has 'More Value Than Anybody is Recognizing' | ||
Do | Intel und TSMC: Neue Partnerschaft belebt den US-Chipsektor | ||
Do | Intel und TSMC: Gemeinsames Chip-Herstellungsprojekt in Planung | ||
Do | Intel plant strategische Partnerschaft mit TSMC zur Halbleiterproduktion |
Unternehmen / Aktien | Kurs | % |
---|---|---|
ELI LILLY AND COMPANY | 722,10 | -3,19 % |
INTEL CORPORATION | 20,350 | +0,05 % |